We have established what we believe is a strong position in intellectual property relevant to our Adnectin™ class of molecules, our PROfusion™ discovery engine, and each of our specific Adnectin products, including our first Adnectin, CT-322.
Strong IP Foundation
Our patent estate includes numerous patents and patent applications
protecting the Adnectin class, PROfusion, and each of our specific
products.